STLN

Starling Oncology, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$3.75

Price (1 Year)

$6.96 $2.51

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %35 / %30
Non-compliant assets / Total market cap %15.1 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

Website

Analysis (Turkish): STLN Hissesi Caiz mi, Helal mi? Starling Oncology, Inc. Katılım Analizi